Economic Burden of Patients with Alk+ Mutation non-Small Cell Lung Cancer After Treatment with Crizotinib: a Canadian Retrospective Observational Study
Ceritinib
ALK inhibitor
Targeted Therapy
DOI:
10.1016/j.jval.2015.09.1142
Publication Date:
2015-10-20T20:53:19Z
AUTHORS (6)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....